Liver resections: Complications and survival outcome

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 7, Issue 3, 2007, Pages 269-279

  Grazi, Gian Luca ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bile duct cancer; Hepatocellular carcinoma; Liver metastasis; Liver resection; Liver surgery; Postoperative complication; Postoperative survival

Indexed keywords

BILIRUBIN; DIURETIC AGENT; FIBRIN GLUE; FRESH FROZEN PLASMA; GELATIN SPONGE; HEMOSTATIC AGENT; HUMAN ALBUMIN; MICROCRYSTALLINE COLLAGEN; OXIDIZED CELLULOSE; PROTHROMBIN;

ASCITES; BILE LEAKAGE; BILIARY TRACT TUMOR; BILIRUBIN BLOOD LEVEL; CANCER RECURRENCE; CLINICAL TRIAL; COST CONTROL; DISEASE FREE SURVIVAL; HEMOSTASIS; HUMAN; ISCHEMIC PRECONDITIONING; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER METASTASIS; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER WEIGHT; OVERALL SURVIVAL; PEROPERATIVE ECHOGRAPHY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROTHROMBIN TIME; REVIEW; SURGICAL APPROACH; SURGICAL EQUIPMENT; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

EID: 34547586042     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.7.3.269     Document Type: Review

References (79)

1. Gozzetti G, Mazziotti A, Grazi GL. HPB Surgery: an independent specialty or a branch of digestive surgery? HPB Surg. 8, 111-113 (1994).
2. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J. Hepatol. 39(6), 1076-1084 (2003).
3. Ton That Tung. Le cancer primaire du foie au Viet-nam. Chirurgie 99,427-436 (1973).
4. Bolondi L, Sofia S, Siringo S et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 48(2), 251-259 (2001).
5. Trevisani F, De Notariis S, Rapaccini G et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am. J. Gastroenterology 97(3), 734-744 (2002).
6. Bruix J Sherman M. Management of hepatocellular carcinoma. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Hepatology 42(5), 1208-1236 (2005).
7. Grazi GL. Web relationships between physicians and individuals seeking information on hepatopancreatobiliary diseases. Arch. Surg. 141(12), 1176-1182 (2006).
8. Yokoyama Y, Nagino M, Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J. Surg. 31(2), 367-374 (2007).
9. Johnson TN, Tucker GT, Tanner MS, Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: a meta- analysis. Liver Transpl. 11(12), 1481-1493 (2005).
10. Kubota K, Makuuchi M, Kusaka K et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. hepatology 260), 1176-1181 (1997).
11. Truant S, Oberlin O, Sergent G et al. Remnant liver volume to body weight ratio ≥ 0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J. Am. Coff. Surg. 204(l), 22-33 (2007).
12. Pang YY, Strasberg SM. The Brisbane 2000 terminology of liver anatomy and resections. J. hepatobiliary Pancreat. Surg. 2, 333-339 (2000).
13. Lin T, Tsu K, Mien C et al. Study on lobectomy of the liver. J. Formosa Med. Assoc. 57, 7422-759 (1958).
14. Lin TY. A simplified technique for hepatic resection: the crush method. Ann. Surg. 180, 285-290 (1974).
15. Liu CL, Fan ST, Cheung ST, Lo CM, Ng IO, Wong J. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann. Surg. 244(2), 194-203 (2006).
16. Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA. How should transection of the liver be performed? A prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann. Surg. 242, 814-823 (2005).
17. Takayama T, Makuuchi M, Kubota K et al. Randomized comparison of ultrasonic vs clamp transection of the liver. Arch. Surg. 136, 922-928 (2001).
18. Lupo L, Gaillerani A, Panzera P, Tandoi F, Di Palma G, Memeo V Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection. Br. J. Surg. 94, 287-291 (2007).
19. Gozzetti G, Mazziotti A, Grazi GL et al. Liver resection without blood transfusion. Br. J. Surg. 82, 1105-1110 (1995).
20. Pringle JH. Note on the arrest of hepatic hemorrhage due to trauma. Ann. Surg. 48, 541-549 (1908).
21. Beighiti J, Noun R, Malafosse R et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann. Surg. 229(3), 369-375 (1999).
22. Clavien PA, Petrowsky H, De Oliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N. Engl. J. Med. 356(15), 1545-1559 (2007).
23. Esaki M, Sano T, Shimada K et al. Randomized clinical trial of hepatectomy using intermittent pedicle occlusion with ischaemic intervals of 15 versus 30 minutes. Br. J. Surg. 93(8), 944-951 (2006).
24. Makuuchi M, Mori T Gunvén P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg. Gynecol. Obstet. 164(2), 155-158 (1987).
25. Figueras I Llado L, Ruiz D et al. Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial. Ann. Surg. 241(4), 582-590 (2005).
26. Grazi GL, Mazziotti A, Jovine E et al. Total vascular exclusion of the liver during hepatic surgery: selective use, extensive use or abuse. Arch. Surg. 132, 1104-1110 (1997).
27. Capussotti L, Muratore A, Ferrero A, Massucco P, Ribero D, Polastri R. Randomized clinical trial of liver resection with and without hepatic pedicle clamping. Br. J. Surg. 93(6), 685-689 (2006).
28. Huguet C, Nordlinger B, Calopin JJ, Bloch P, Gallot D. Normothermic hepatic vascular exclusion for extensive hepatectomy. Surg. Gynecol. Obstet. 147(5), 689-693 (1978).
29. Delva E, Camus Y, Nordlinger B et al. Vascular occlusions for liver resections: operative management and tolerance to hepatic ischemia. Ann. Surg. 209, 211-218 (1989).
30. Cherqui D, Malassagne B, Colau PH et al. Hepatic vascular exclusion with preservation of the caval flow for liver resections. Ann. Surg. 230(l), 24-30 (1999).
31. Melendez JA, Arstan V, Fischer ME et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J. Am. Coll. Surg. 187(6), 620-625 (1998).
32. Figueras J Llado L, Miro M et al. Application of fibrin glue sealant after hepatectomy does not seem justified. Results of a randomized study in 300 patients. Ann. Surg. (2007) (In Press).
33. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 240(2), 205-213 (2004).
34. Imamura H, Seyama Y, Kokudo N et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch. Surg. 138(11), 1198-1206 (2003).
35. Batzan S, Belghiti J, Farges O et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann. Surg. 242(6), 824-828 (2005).
36. Mullen JT, Ribero D, Reddy SK et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J. Am. Coll. Surg. 204(5), 854-862 (2007).
37. Vauthey JN, Chaoui A, Do KA et al. Standardized measurement of the future liver remnant before extended liver resection: methodology and clinical associations. Surgery 127, 512-519 (2000).
38. Kiuchi T, Kasahara M, Uryuhara K et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 67 (2), 321-327 (1999).
39. Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO. Safety of donors in live donor liver transplantation using right lobe grafts. Arch. Surg. 135(3), 336-340 (2000).
40. Makuuchi M, Thai BL, Takayasu K et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107(5), 521-527 (1990).
41. Imamura H, Shimada R, Kubota M et al. Preoperative portal vein embolization: an audit of 84 patients. hepatology 29 (4). 1099-1105 (1999).
42. Azoulay D, Castaing D, Krissat J et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatoceflular carcinoma in injured liver. Ann. Surg. 232(5), 665-672 (2000).
43. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann. Surg. 232(6), 777-785 (2000).
44. Ercolani G, Principe A, Ravaioli M, Cescon M, Grazi GL. Long-term survival after two-stage hepatectomy for colorectal metastases: a case report. hepatogastroenterology 5l(56), 592-594 (2004).
45. Child CG II, Turcotte JG. Surgery and portal hypertension. In: The Liver and Portal Hypertension. Child CG III (Ed.). Saunders, PA, USA, 50-58 (1964).
46. Pugh RN, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60, 646-649 (1973).
47. Ercolani G, Grazi GL, Callivà R et al. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery 127(4), 464-471 (2000).
48. Mullin EJ, Metcalfe MS, Maddern GJ. How much liver resection is too much? Am. J. Surg. 190, 87-97 (2005).
49. Cucchetti A, Ercolani G, Vivarelli M et al. Impact of Model for End-Stage Liver Disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 12, 966-971 (2006).
50. Bruix J, Castells A, Bosch J et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111(4), 1018-1022 (1996).
51. Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann. Surg. 238(5), 720-727 (2003).
52. Nagino M, Kamiya J, Arai T, Nishio H, Ebata T, Nimura Y. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery 137(2), 148-155 (2005).
53. Tsao JI, Nimura Y, Kamiya J et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann. Surg. 232(2), 166-174 (2000).
54. Grazi GL, Ercolani G, Pierangeli F et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann. Surg. 234, 71-78 (2001).
55. Cucchetti A, Ercolani G, Cescon M et al. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J. Am. Coll. Surg. 203(5), 670-676 (2006).
56. Hayashibe A, Sakamoto K, Shinbo M, Makimoto S, Nakamoto T. New method for prevention of bile leakage after hepatic resection. J. Surg. Oncol. 94(1), 57-60 (2006).
57. Yamashita Y, Hamatsu T, Rikimaru T et al. Bile leakage after hepatic resection. Ann. Surg. 233(1), 45-50 (2001).
58. Ijichi M, Takayama T, Toyoda H, Sano K, Kubota K, Makuuchi M. Randomized trial of the usefulness of a bile leakage test during hepatic resection. Arch. Surg. 135(12), 1395-1400 (2000).
59. Tanaka S, Hirohashi K, Tanaka H et al. Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J. Am. Coll. Surg. 195(4), 484-489 (2002).
60. Grazi GL, Cescon M, Ravaioli M et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment. Pharmacol. Ther. 17(Suppl. 2), 119-129 (2003).
61. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br. J. Cancer 94, 982-999 (2006).
62. Ebara M, Ohto M, Shinagawa T et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 90(2), 289-298 (1986).
63. Llovet JM, Bustamante J, Castells A et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29(1), 62-67 (1999).
64. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin. Liver Dis. 25(2), 181-200 (2005).
65. Ercolani G, Grazi GL, Ravaioli M et al. Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann. Surg. 237(4), 536-543 (2003).
66. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann. Surg. 214(2), 114-117 (1991).
67. Chen YJ, Yeh SH, Chen JT et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 119, 431-440 (2000).
68. Ng IO, Guan XY, Poon RT, Fan ST, Lee JM. Determination of the molecular relationship between multiple tumor nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J. Pathol. 199(3), 345-353 (2003).
69. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 343, 1405-1410 (1994).
70. Ercolani G, Grazi GL, Ravaioli M et al. Liver resection for multiple colorectal metastases: parenchymal involvement and total tumor volume, not number or location, significantly affect long term survival. Arch. Surg. 137(10), 1187-1192 (2002).
71. Garden OJ, Rees M, Poston GJ et al. Guidelines for resection of colorectal cancer liver metastases. Gut 55, 1-8 (2006).
72. Biasco G, Derenzini E, Grazi GL et al. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat. Rev. 32(3), 214-228 (2006).
73. Sugawara G, Isogai M, Kaneoka Y, Suzuki M, Yamaguchi A. Repeat hepatectomy for recurrent colorectal metastases. Surg. Today 35, 282-289 (2005).
74. Yan TD, Lian KQ, Chang D, Morris DL. Management of intrahepatic recurrence after curative treatment of colorectal liver metastases. Br. J. Surg. 93, 854-859 (2006).
75. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann. Surg. 244(2), 254-259 (2006).
76. Grazi GL, Cescon M, Pierangeli F, Ercolani M, Gardini A, Cavallari A. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology 47(32), 481-486 (2000).
77. Ercolani G, Grazi GL, Ravaioli M et al. The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann. Surg. Oncol. 12(6), 459-466 (2005).
78. Weitz J, Blumgart LH, Fong Y et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann. Surg. 241(2), 269-276 (2005).
79. Adam R, Chiche L, Aloia T et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann. Surg. 244(4), 524-535 (2006).